CSPC Pharmaceutical Group says Chinese authorities have approved its domestically developed mRNA vaccine against COVID-19.
China approves its first mRNA COVID-19 vaccine
China has approved its first domestically developed mRNA vaccine against COVID-19, CSPC Pharmaceutical Group Ltd says, a major achievement in a country that has declined to use foreign coronavirus shots to support domestic research.
China, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vaccines using messenger RNA (mRNA) technology since early 2020.
The long-awaited approval comes as infections have fallen sharply across China since it suddenly dropped its strict “zero-COVID” curbs in December, making the sales outlook for the newly approved vaccine moderate.
But it would give China an additional option to tackle future outbreaks and a base for development against newly emerging variants, scientists said.